Evidence map›Paper›PMID 35543856›Full record

ArticleApplied biochemistry and biotechnology2022

Optimizing Chitosan/Collagen Type I/Nanohydroxyapatite Cross-linked Porous Scaffolds for Bone Tissue Engineering.

Ayşe Karakeçili, Serdar Korpayev, Kaan Orhan

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Application of collagen in bone regeneration.Journal of orthopaedic translation · 2025
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ayşe KarakeçiliChemical Engineering Department, Faculty of Engineering, Ankara University, 06100, Ankara, Turkey. akarakecili@eng.ankara.edu.tr.
Serdar KorpayevBiotechnology Institute, Ankara University, 06100, Ankara, Turkey. serdarkorpe@gmail.com.ORCID http://orcid.org/0000-0001-8852-8966
Kaan OrhanDepartment of Dentomaxillofacial Radiology, Faculty of Dentistry, Ankara University, Ankara, 06560, Turkey.

Funding

Türkiye Bilimsel ve Teknolojik Araştirma Kurumu 116M437
6 · The paper itself

Abstract

Bio-composite scaffolds mimicking the natural microenvironment of bone tissue offer striking advantages in material-guided bone regeneration. The combination of biodegradable natural polymers and bioactive ceramics that leverage potent bio-mimicking cues has been an active strategy to achieve success in bone tissue engineering. Herein, a competitive approach was followed to point out an optimized bio-composite scaffold in terms of scaffold properties and stimulation of osteoblast differentiation. The scaffolds, composed of chitosan/collagen type I/nanohydroxyapatite (Chi/Coll/nHA) as the most attractive components in bone tissue engineering, were analyzed. The scaffolds were prepared by freeze-drying method and cross-linked using different types of cross-linkers. Based on the physicochemical and mechanical characterization, the scaffolds were eliminated comparatively. All types of scaffolds displayed highly porous structures. The cross-linker type and collagen content had prominent effects on mechanical strength. Glyoxal cross-linked structures displayed optimum mechanical and structural properties. The MC3T3-E1 proliferation, osteogenic-related gene expression, and matrix mineralization were better pronounced in collagen presence and triggered as collagen type I amount was increased. The results highlighted that glyoxal cross-linked scaffolds containing equal amounts of Chi and Coll by mass and 1% (w/v) nHA are the best candidates for osteoblast differentiation and matrix mineralization.

Indexed as

ChitosanTissue EngineeringBone and BonesCollagenCollagen Type IDurapatiteGlyoxalOsteogenesisPorosityTissue ScaffoldsChitosanCollagenCollagen Type IDurapatiteGlyoxalBio-composite scaffoldsBone tissue engineeringHydroxyapatiteNatural polymersOsteoblast differentiation

Identifiers

PMID35543856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.